|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zuo T, Zeng H, Zhang S
and He J: National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 28:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He Y, Li D, Song G, Li Y, Liang D, Jin J,
Wen D and Shan B: Lung cancer burden has increased during the last
40 years in Hebei Province, China. Thorac Cancer. 7:323–332. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raaschou-Nielsen O, Andersen ZJ, Beelen R,
Samoli E, Stafoggia M, Weinmayr G, Hoffmann B, Fischer P,
Nieuwenhuijsen MJ, Brunekreef B, et al: Air pollution and lung
cancer incidence in 17 European cohorts: Prospective analyses from
the European Study of Cohorts for Air Pollution Effects (ESCAPE).
Lancet Oncol. 14:813–822. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hamra GB, Guha N, Cohen A, Laden F,
Raaschou-Nielsen O, Samet JM, Vineis P, Forastiere F, Saldiva P,
Yorifuji T and Loomis D: Outdoor particulate matter exposure and
lung cancer: A systematic review and meta-analysis. Environ Health
Perspect. 122:906–911. 2014.PubMed/NCBI
|
|
6
|
Luengo-Fernandez R, Leal J, Gray A and
Sullivan R: Economic burden of cancer across the European Union: A
population-based cost analysis. Lancet Oncol. 14:1165–1174. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Melloni G, Muriana P, Bandiera A, Fontana
R, Maggioni D, Russo V, Doglioni C and Zannini P: Prognostic role
of liver X receptor-alpha in resected stage II and III non-small
cell lung cancer. Clin Respir J Jul. 12:2016.(Epub ahead of
print).
|
|
8
|
Rami-Porta R, Bolejack V, Giroux DJ,
Chansky K, Crowley J, Asamura H and Goldstraw P; International
Association for the Study of Lung Cancer Staging and Prognostic
Factors Committee, Advisory Board Members and Participating
Institutions, : The IASLC lung cancer staging project: The new
database to inform the eighth edition of the TNM classification of
lung cancer. J Thorac Oncol. 9:1618–1624. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yutong H, Xiaoli X, Shumei L, Shan S, Di L
and Baoen S: Increased neutrophil-lymphocyte ratio is a poor
prognostic factor in patients with esophageal cancer in a high
incidence area in China. Arch Med Res. 46:557–563. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wculek SK and Malanchi I: Neutrophils
support lung colonization of metastasis-initiating breast cancer
cells. Nature. 528:413–417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen S, Guo J, Feng C, Ke Z, Chen L and
Pan Y: The preoperative platelet-lymphocyte ratio versus
neutrophil-lymphocyte ratio: Which is better as a prognostic factor
in oral squamous cell carcinoma? Ther Adv Med Oncol. 8:160–167.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W
and Wu X: Preoperative neutrophil-to-lymphocyte ratio as a
predictive and prognostic factor for high-grade serous ovarian
cancer. PLoS One. 11:e01561012016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marchioni M, Primiceri G, Ingrosso M,
Filograna R, Castellan P, De Francesco P and Schips L: The clinical
use of the neutrophil to lymphocyte ratio (NLR) in urothelial
cancer: A systematic review. Clin Genitourin Cancer. 14:473–484.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maeda Y, Kawahara T, Koizumi M, Ito H,
Kumano Y, Ohtaka M, Kondo T, Mochizuki T, Hattori Y, Teranishi J,
et al: Lack of an association between neutrophil-to-lymphocyte
ratio and PSA failure of prostate cancer patients who underwent
radical prostatectomy. Biomed Res Int. 2016:61973532016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee H, Um SJ, Kim YS, Kim DK, Jang AS,
Choi HS, Kim YH, Kim TE, Yoo KH and Jung KS: Association of the
neutrophil-to-lymphocyte ratio with lung function and exacerbations
in patients with chronic obstructive pulmonary disease. PLoS One.
11:e01565112016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen JL, Lv XD, Ma H, Chen JR and Huang
JA: Detection of cancer embryo antigen and endothelin-1 in exhaled
breath condensate: A novel approach to investigate non-small cell
lung cancer. Mol Clin Oncol. 5:124–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gandara DR, Grimminger P, Mack PC, Lara PN
Jr, Li T, Danenberg PV and Danenberg KD: Association of epidermal
growth factor receptor activating mutations with low ERCC1 gene
expression in non-small cell lung cancer. J Thorac Oncol.
5:1933–1938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Atwater T and Massion PP: Biomarkers of
risk to develop lung cancer in the new screening era. Ann Transl
Med. 4:1582016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Field RW and Withers BL: Occupational and
environmental causes of lung cancer. Clin Chest Med. 33:681–703.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cruz CS Dela, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Straif K, Cohen A and Samet J: Air
pollution and cancer. International Agency for Research on Cancer;
Lyon, France: pp. 123–148. 2014
|
|
22
|
Oberli LS, Valeri F, Korol D, Rohrmann S
and Dehler S: 31 years of lung cancer in the canton of Zurich,
Switzerland: Incidence trends by sex, histology and laterality.
Swiss Med Wkly. 146:w143272016.PubMed/NCBI
|
|
23
|
Cedrés S, Nuñez I, Longo M, Martinez P,
Checa E, Torrejón D and Felip E: Serum tumor markers CEA,
CYFRA21-1, and CA-125 are associated with worse prognosis in
advanced non-small-cell lung cancer (NSCLC). Clin Lung Cancer.
12:172–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Retraction: HMGA2 functions as a competing
endogenous RNA to promote lung cancer progression. Nature.
523:3702015. View Article : Google Scholar
|
|
25
|
Retraction note to: Identification of
featured biomarkers in different types of lung cancer with DNA
microarray. Mol Biol Rep. 42:14812015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Agathanggelou A, Honorio S, Macartney DP,
Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R,
Shaw JA, et al: Methylation associated inactivation of RASSF1A from
region 3p21.3 in lung, breast and ovarian tumours. Oncogene.
20:1509–1518. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Abdurahman A, Anwar J, Turghun A, Niyaz M,
Zhang L and Awut I: Epidermal growth factor receptor gene mutation
status and its association with clinical characteristics and tumor
markers in non-small-cell lung cancer patients in Northwest China.
Mol Clin Oncol. 3:847–850. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sherwood JL, Corcoran C, Brown H, Sharpe
AD, Musilova M and Kohlmann A: Optimised pre-analytical methods
improve KRAS mutation detection in circulating tumour DNA (ctDNA)
from patients with non-small cell lung cancer (NSCLC). PLoS One.
11:e01501972016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mantovani A and Pierotti MA: Cancer and
inflammation: A complex relationship. Cancer Lett. 267:180–181.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chao C and Hellmich MR: Gastrin,
inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes
Obes. 17:33–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adach A, Ellert-Miklaszewska A and
Kaminska B: Molecular characterization of STAT signaling in
inflammation and tumorigenesis. Methods Mol Biol. 512:265–278.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chai EZ, Siveen KS, Shanmugam MK, Arfuso F
and Sethi G: Analysis of the intricate relationship between chronic
inflammation and cancer. Biochem J. 468:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bollrath J and Greten FR: IKK/NF-kappaB
and STAT3 pathways: Central signalling hubs in
inflammation-mediated tumour promotion and metastasis. EMBO Rep.
10:1314–1319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pan QX, Su ZJ, Zhang JH, Wang CR and Ke
SY: A comparison of the prognostic value of preoperative
inflammation-based scores and TNM stage in patients with gastric
cancer. Onco Targets Ther. 8:1375–1385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shiels MS, Pfeiffer RM, Hildesheim A,
Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G,
Caporaso NE, et al: Circulating inflammation markers and
prospective risk for lung cancer. J Natl Cancer Inst.
105:1871–1880. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sherman M: Hepatocellular carcinoma:
Epidemiology, risk factors, and screening. Semin Liver Dis.
25:143–154. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW:
Inflammation-related factors predicting prognosis of gastric
cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Banat GA, Tretyn A, Pullamsetti SS,
Wilhelm J, Weigert A, Olesch C, Ebel K, Stiewe T, Grimminger F,
Seeger W, et al: Immune and inflammatory cell composition of human
lung cancer stroma. PLoS One. 10:e01390732015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ruffini E, Asioli S, Filosso PL, Lyberis
P, Bruna MC, Macrì L, Daniele L and Oliaro A: Clinical significance
of tumor-infiltrating lymphocytes in lung neoplasms. Ann Thorac
Surg. 87:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Absenger G, Szkandera J, Pichler M, Stotz
M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H,
Stojakovic T and Gerger A: A derived neutrophil to lymphocyte ratio
predicts clinical outcome in stage II and III colon cancer
patients. Br J Cancer. 109:395–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ahn HK, Hwang IC, Lee JS, Sym SJ, Cho EK
and Shin DB: Neutrophil-lymphocyte ratio predicts survival in
terminal cancer patients. J Palliat Med. 19:437–441. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abbasciano V, Bianchi MP, Trevisani L,
Sartori S, Gilli G and Zavagli G: Platelet activation and
fibrinolysis in large bowel cancer. Oncology. 52:381–384. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zahorec R: Ratio of neutrophil to
lymphocyte counts-rapid and simple parameter of systemic
inflammation and stress in critically ill. Bratisl Lek Listy.
102:5–14. 2001.(In English, Slovak). PubMed/NCBI
|
|
44
|
Aggarwal BB, Shishodia S, Sandur SK,
Pandey MK and Sethi G: Inflammation and cancer: How hot is the
link? Biochem Pharmacol. 72:1605–1621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sethi G, Shanmugam MK, Ramachandran L,
Kumar AP and Tergaonkar V: Multifaceted link between cancer and
inflammation. Biosci Rep. 32:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kundu JK and Surh YJ: Inflammation:
Gearing the journey to cancer. Mutat Res. 659:15–30. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jackson JR, Seed MP, Kircher CH,
Willoughby DA and Winkler JD: The codependence of angiogenesis and
chronic inflammation. FASEB J. 11:457–465. 1997.PubMed/NCBI
|
|
49
|
Kusumanto YH, Dam WA, Hospers GA, Meijer C
and Mulder NH: Platelets and granulocytes, in particular the
neutrophils, form important compartments for circulating vascular
endothelial growth factor. Angiogenesis. 6:283–287. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
